172 related articles for article (PubMed ID: 22352782)
1. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
[TBL] [Abstract][Full Text] [Related]
2. 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis.
Zhang L; Brodney MA; Candler J; Doran AC; Duplantier AJ; Efremov IV; Evrard E; Kraus K; Ganong AH; Haas JA; Hanks AN; Jenza K; Lazzaro JT; Maklad N; McCarthy SA; Qian W; Rogers BN; Rottas MD; Schmidt CJ; Siuciak JA; Tingley FD; Zhang AQ
J Med Chem; 2011 Mar; 54(6):1724-39. PubMed ID: 21366332
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 3-cyclopropylmethyl-7-(4-phenylpiperidin-1-yl)-8-trifluoromethyl[1,2,4]triazolo[4,3-a]pyridine (JNJ-42153605): a positive allosteric modulator of the metabotropic glutamate 2 receptor.
Cid JM; Tresadern G; Vega JA; de Lucas AI; Matesanz E; Iturrino L; Linares ML; Garcia A; Andrés JI; Macdonald GJ; Oehlrich D; Lavreysen H; Megens A; Ahnaou A; Drinkenburg W; Mackie C; Pype S; Gallacher D; Trabanco AA
J Med Chem; 2012 Oct; 55(20):8770-89. PubMed ID: 23072213
[TBL] [Abstract][Full Text] [Related]
4. Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor.
Tresadern G; Cid JM; Macdonald GJ; Vega JA; de Lucas AI; García A; Matesanz E; Linares ML; Oehlrich D; Lavreysen H; Biesmans I; Trabanco AA
Bioorg Med Chem Lett; 2010 Jan; 20(1):175-9. PubMed ID: 19932615
[TBL] [Abstract][Full Text] [Related]
5. CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor.
Lindemann L; Jaeschke G; Michalon A; Vieira E; Honer M; Spooren W; Porter R; Hartung T; Kolczewski S; Büttelmann B; Flament C; Diener C; Fischer C; Gatti S; Prinssen EP; Parrott N; Hoffmann G; Wettstein JG
J Pharmacol Exp Ther; 2011 Nov; 339(2):474-86. PubMed ID: 21849627
[TBL] [Abstract][Full Text] [Related]
6. Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep-wake architecture.
Ahnaou A; Dautzenberg FM; Geys H; Imogai H; Gibelin A; Moechars D; Steckler T; Drinkenburg WH
Eur J Pharmacol; 2009 Jan; 603(1-3):62-72. PubMed ID: 19046965
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
Layton ME; Reif AJ; Hartingh TJ; Rodzinak K; Dudkin V; Wang C; Arrington K; Kelly MJ; Garbaccio RM; O'Brien JA; Magliaro BC; Uslaner JM; Huszar SL; Fillgrove KL; Tang C; Kuo Y; Jacobson MA
Bioorg Med Chem Lett; 2016 Feb; 26(4):1260-4. PubMed ID: 26810316
[TBL] [Abstract][Full Text] [Related]
8. Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist.
Ito S; Satoh A; Nagatomi Y; Hirata Y; Suzuki G; Kimura T; Satow A; Maehara S; Hikichi H; Hata M; Kawamoto H; Ohta H
Bioorg Med Chem; 2008 Nov; 16(22):9817-29. PubMed ID: 18849168
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and metabotropic glutamate receptor activity of S-oxidized variants of (-)-4-amino-2-thiabicyclo-[3.1.0]hexane-4,6-dicarboxylate: identification of potent, selective, and orally bioavailable agonists for mGlu2/3 receptors.
Monn JA; Massey SM; Valli MJ; Henry SS; Stephenson GA; Bures M; Hérin M; Catlow J; Giera D; Wright RA; Johnson BG; Andis SL; Kingston A; Schoepp DD
J Med Chem; 2007 Jan; 50(2):233-40. PubMed ID: 17228865
[TBL] [Abstract][Full Text] [Related]
11. mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats.
Ahnaou A; Lavreysen H; Tresadern G; Cid JM; Drinkenburg WH
PLoS One; 2015; 10(12):e0144017. PubMed ID: 26658273
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.
Bischoff F; Berthelot D; De Cleyn M; Macdonald G; Minne G; Oehlrich D; Pieters S; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter I; Zaja M; Borghys H; Masungi C; Mercken M; Gijsen HJ
J Med Chem; 2012 Nov; 55(21):9089-106. PubMed ID: 22650177
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, evaluation, and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging.
Andrés JI; Alcázar J; Cid JM; De Angelis M; Iturrino L; Langlois X; Lavreysen H; Trabanco AA; Celen S; Bormans G
J Med Chem; 2012 Oct; 55(20):8685-99. PubMed ID: 22992024
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.
Sheffler DJ; Pinkerton AB; Dahl R; Markou A; Cosford ND
ACS Chem Neurosci; 2011 Aug; 2(8):382-93. PubMed ID: 22860167
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor.
Cid JM; Duvey G; Tresadern G; Nhem V; Furnari R; Cluzeau P; Vega JA; de Lucas AI; Matesanz E; Alonso JM; Linares ML; Andrés JI; Poli SM; Lutjens R; Himogai H; Rocher JP; Macdonald GJ; Oehlrich D; Lavreysen H; Ahnaou A; Drinkenburg W; Mackie C; Trabanco AA
J Med Chem; 2012 Mar; 55(5):2388-405. PubMed ID: 22364337
[TBL] [Abstract][Full Text] [Related]
17. New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of N-propyl-8-chloro-6-substituted isoquinolones.
Trabanco AA; Duvey G; Cid JM; Macdonald GJ; Cluzeau P; Nhem V; Furnari R; Behaj N; Poulain G; Finn T; Lavreysen H; Poli S; Raux A; Thollon Y; Poirier N; D'Addona D; Andrés JI; Lutjens R; Le Poul E; Imogai H; Rocher JP
Bioorg Med Chem Lett; 2011 Feb; 21(3):971-6. PubMed ID: 21232953
[TBL] [Abstract][Full Text] [Related]
18. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
Galici R; Echemendia NG; Rodriguez AL; Conn PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM).
Cid JM; Tresadern G; Vega JA; de Lucas AI; Del Cerro A; Matesanz E; Linares ML; García A; Iturrino L; Pérez-Benito L; Macdonald GJ; Oehlrich D; Lavreysen H; Peeters L; Ceusters M; Ahnaou A; Drinkenburg W; Mackie C; Somers M; Trabanco AA
J Med Chem; 2016 Sep; 59(18):8495-507. PubMed ID: 27579727
[TBL] [Abstract][Full Text] [Related]
20. Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators.
Pinkerton AB; Cube RV; Hutchinson JH; James JK; Gardner MF; Schaffhauser H; Rowe BA; Daggett LP; Vernier JM
Bioorg Med Chem Lett; 2004 Dec; 14(23):5867-72. PubMed ID: 15501058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
